Actively Recruiting
Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma in Pre-hospital Care
Led by Centre Hospitalier Universitaire de Nice · Updated on 2026-03-30
550
Participants Needed
3
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the use of capillary lactatemia to assess the severity of potentially severe polytrauma patients before they reach the hospital. Current tools like vital signs and shock scores have limitations and can be subjective. Capillary lactatemia is a simple and quick test that could help predict poor outcomes in trauma patients, similar to venous lactatemia, but has not yet been studied in this context. The study involves collecting capillary blood samples during the transfer of trauma patients to emergency facilities. These samples are analyzed to measure lactate levels at inclusion and again six hours later. The goal is to see if capillary lactate levels can improve the prediction of severe outcomes and help guide better patient management in the pre-hospital setting. Participants will be trauma patients aged 18 or older, who have suffered serious injuries like road accidents or falls over two meters and require emergency medical assistance. The study measures lactate values at two time points and monitors patient outcomes. Consent is obtained from the patient or a relative, and pregnant women can participate safely. The study runs until December 2027 and includes continuous assessment during hospital transfer and emergency care.
CONDITIONS
Brief Title
Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 18 years of age
- Experienced a potentially serious pre-hospital trauma such as a road accident or a fall from more than 2 metres
- Required dispatch of a mobile emergency and resuscitation service team
- Transferred to an emergency facility with medical assistance
- Signed consent by the patient or a relative after the event if immediate consent was not possible
- Pregnant women may participate without risk
You will not qualify if you...
- Patients with isolated peripheral limb trauma (wrist, elbow, knee, ankle, shoulder)
- Patients under legal protection such as guardianship or curatorship
- Patients in cardiorespiratory arrest when taken into care by emergency medical services
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - From inclusion to 6 hours post-inclusion
Participants undergo capillary blood sampling during the hospital transfer after a severe trauma event.
2 sampling timepoints: at inclusion and 6 hours later
Trial Site Locations
Total: 3 locations
1
Antibes Hospital
Antibes, France, 06400
Not Yet Recruiting
2
Cannes hospital
Cannes, France, 06000
Not Yet Recruiting
3
Nice University Hospital
Nice, France, 06000
Actively Recruiting
Research Team
M
Marta FERNANDES FEIRRERA, PH
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here